Dr. Steven David Kavy M.D.

Recommended Articles

• Cough Medicine for Cystic Fibrosis

  Medications for cystic fibrosis can help control the mucus in the lungs and keep the lungs’ normal functioning as much as possible. What is Cystic Fibrosis?Cystic fibrosis is a genetic disease known to affect the cells that make mucus, digestive fluids, and sweat. Usually, these fluids are thin...

• What to Do if You Have a Lung Injury

  For the past several years, lung injuries have remained one of the most common cases to be noted in the emergency units of several hospitals. There are different types of lung injuries that require medical attention as soon as possible. There are different ways by which a person may end up with a...

• What Is Cyanosis and Why Does It Occur?

  IntroductionCyanosis is the medical term for a bluish discoloration of the skin, nails, toes, and mucous membranes. It is generally caused by low levels of oxygen in the blood. Normally, blood appears bright red when it is fully oxygenated. However, when blood does not have enough oxygen, it turns...

• What Is Emphysema? Home Remedies for Emphysema Patients

  Emphysema is a form of chronic lung disease and one of the main types of chronic obstructive pulmonary disease (COPD). This disease is regarded as "obstructive" because people who are suffering from emphysema exhale air as if there is an obstruction. There are various factors that can cause...

• How Does Rheumatoid Arthritis Affect the Lungs?

  An autoimmune disorder, rheumatoid arthritis (RA) presents as chronic pain and inflammation in the joints. Joint damage usually occurs on both sides of the body, meaning that if a joint in an  arm or leg is affected, the same joint in the other arm or leg will likely be affected as well. ...

• FDA Approves Orkambi to Treat Young Children with Cystic Fibrosis

  Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...